+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
From
From
From
From
Angelman Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Angelman Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Anal Fissure Treatment Global Market Report 2024 - Product Thumbnail Image

Anal Fissure Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Biosimilar Commercial Strategies and Tactics - Product Thumbnail Image

Biosimilar Commercial Strategies and Tactics

  • Report
  • May 2019
  • 67 Pages
  • Global
From
From
From
From
Neurodegenerative Diseases Therapeutics Market 2024-2028 - Product Thumbnail Image

Neurodegenerative Diseases Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 155 Pages
  • Global
From
From
Chronic Pain Global Market Report 2024 - Product Thumbnail Image

Chronic Pain Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
Loading Indicator